Clinical Trial Update: Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer

View source ↗

Summary

The document reports a clinical trial investigating whether methylprednisolone acetate can prevent seroma after mastectomy for primary breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Methylprednisolone acetate (Methylprednisolone acetate)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Breast Cancer | Status: UNKNOWN